Records containing: Neuromyelitis Optica Spectrum Disorder (NMOSD)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-16Observational Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
-
CLINICAL_TRIALS study record update · 2026-04-13An Open-Label Clinical Study to Evaluate the Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
-
CLINICAL_TRIALS study record update · 2026-02-19A Multicenter Non-interventional Single-arm Retrospective-prospective Observational Study in Therapeutic Approaches on AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) in Real Clinical Practice in Russia
-
CLINICAL_TRIALS study record update · 2025-06-23Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder: A Target Trial Emulation Study
-
CLINICAL_TRIALS study record update · 2025-04-17Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-08-16A Phase Ib/III Multi-center, Randomized and Positive Control Study to Evaluate IMC-002 Safety and Efficacy in in Neuromyelitis Optica Spectrum Disorder (NMOSD) Patients